On the other hand, the current studydoes not allow any conclusion about the potential association of changes in fibrosis or resolution of NASH withPROs. Because these endpoints are set by regulatoryagencies for clinical trials of NASH at the present time,future studies are needed to assess improvement offibrosis without worsening NASH or resolution of NASHwithout worsening fibrosis on PROs.